Clean Energy Fuels Corp. (CLNE)

Orchard Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	132.09	89.51	104.94	123.95	99.45	108.98
Short-Term Investments	108.67	127.97	158.19	139.57	129.72	29.53
Cash & Short-Term Investments	240.76	217.48	263.13	263.52	229.17	138.51
Cash Growth	-3.43%	-17.35%	-0.15%	14.99%	65.46%	30.50%
Accounts Receivable	91.13	112.68	112.01	102.93	93.24	69.24
Other Receivables	4.88	12.62	11.68	11.59	19.61	16.93
Receivables	98.82	127.67	126.02	114.52	112.85	86.17
Inventory	45.37	43.43	45.34	37.14	31.3	28.1
Prepaid Expenses	19.93	21.58	31.08	30.7	34.58	8.43
Restricted Cash	2.11	2.05	2.02	2	-	-
Other Current Assets	0.87	1.55	2.59	23.84	2.04	1.84
Total Current Assets	407.87	413.77	470.18	471.72	409.94	263.04
Property, Plant & Equipment	411.85	455.92	424.08	316.65	304.3	316.88
Long-Term Investments	255.59	265.27	258.77	193.27	109.81	27.96
Goodwill	-	64.33	64.33	64.33	64.33	64.33
Other Intangible Assets	5.5	6.37	6.37	5.92	5.5	0.46
Long-Term Accounts Receivable	1.75	1.95	2.43	2.98	3.53	4
Other Long-Term Assets	33.3	1.08	2.04	5.12	11.75	15.6
Total Assets	1,116	1,244	1,259	1,082	957.07	715.03
Accounts Payable	28.49	33.3	57	44.44	24.35	17.31
Accrued Expenses	88.7	105.56	91.53	90.08	75.16	52.35
Current Portion of Long-Term Debt	0.05	0.04	0.04	0.09	12.85	3.59
Current Portion of Leases	9.34	8.95	8.45	5.15	4.4	3.66
Current Unearned Revenue	8.84	6.87	4.94	5.97	7.25	2.64
Other Current Liabilities	8.84	-	1.88	2.42	1.9	0.28
Total Current Liabilities	144.25	154.72	163.82	148.15	125.9	79.84
Long-Term Debt	277.87	265.33	261.12	145.47	23.22	82.09
Long-Term Leases	86.56	90.82	90.9	51.05	41.86	26.25
Long-Term Unearned Revenue	0.04	0.08	0.15	-	-	0.06
Other Long-Term Liabilities	10.27	13.42	9.81	10.22	10.68	3.94
Total Liabilities	519	524.36	525.81	354.89	201.66	192.18
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	1,761	1,730	1,658	1,554	1,520	1,192
Retained Earnings	-1,168	-1,013	-929.47	-829.98	-771.24	-678.1
Comprehensive Income & Other	-2.27	-4.3	-2.12	-3.72	-1.62	-0.21
Total Common Equity	590.82	713.27	726.77	719.99	747.08	513.51
Minority Interest	6.03	6.26	6.88	7.48	8.34	9.34
Shareholders' Equity	596.85	719.53	733.65	727.47	755.41	522.85
Total Liabilities & Equity	1,116	1,244	1,259	1,082	957.07	715.03
Total Debt	373.82	365.13	360.51	201.76	82.32	115.59
Net Cash (Debt)	-133.07	-147.65	-97.38	61.76	146.86	22.91
Net Cash Growth	-	-	-	-57.95%	540.92%	-
Net Cash Per Share	-0.60	-0.66	-0.44	0.28	0.69	0.11
Filing Date Shares Outstanding	219.29	223.61	223.24	222.73	222.5	199.22
Total Common Shares Outstanding	219.19	223.46	223.03	222.44	222.68	198.49
Working Capital	263.61	259.05	306.35	323.57	284.03	183.2
Book Value Per Share	2.70	3.19	3.26	3.24	3.35	2.59
Tangible Book Value	585.32	642.58	656.08	649.75	677.25	448.71
Tangible Book Value Per Share	2.67	2.88	2.94	2.92	3.04	2.26
Land	20.6	19.19	7.4	3.48	3.48	3.48
Machinery	747.69	743.63	691.11	627.33	615.25	608.61
Construction In Progress	101.36	134.06	125.39	91.11	74.96	73.27

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q